Literature DB >> 3082541

Chronic undernutrition/growth retardation in cystic fibrosis.

V L Soutter, P Kristidis, M A Gruca, K J Gaskin.   

Abstract

There is now sufficient evidence to prove that the maintenance of a high energy normally balanced diet prevents malnutrition/growth retardation and may well enhance prognosis in patients with CF. Most patients are able to tolerate the normal to high fat content without undue problems with steatorrhoea and with the recent advent of more effective enzyme replacement therapy, this should be even less of a problem. Conversely, there is an equally large bulk of evidence to indicate that the maintenance of a low fat diet, while controlling symptoms from steatorrhoea in some patients, is energy depriving and produces growth failure. In children or teenagers who are presently growth retarded, installation of a high energy intake may improve growth in some, but not in others. Further investigation of the latter patients is required to evaluate their persistent anorexia and advantages and disadvantages of nutritional supplementation by invasive techniques. Certainly growth and wellbeing can be vastly improved. However, such studies may well have to be multicentered to obtain sufficient patients to control for the many variables involved, in order to demonstrate the effects on pulmonary function.

Entities:  

Mesh:

Year:  1986        PMID: 3082541

Source DB:  PubMed          Journal:  Clin Gastroenterol        ISSN: 0300-5089


  11 in total

1.  Normal growth in cystic fibrosis associated with a specialised centre.

Authors:  C E Collins; L MacDonald-Wicks; S Rowe; E V O'Loughlin; R L Henry
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  Nutritional strategies in cystic fibrosis: current issues.

Authors:  A MacDonald; C Holden; G Harris
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

3.  Bone mineral status in 134 patients with cystic fibrosis.

Authors:  E M Laursen; C Molgaard; K F Michaelsen; C Koch; J Müller
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 4.  Rationale of modern dietary recommendations in cystic fibrosis.

Authors:  J M Littlewood; A MacDonald
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

Review 5.  Cystic fibrosis--a gastroenterological cornucopia.

Authors:  P L Zentler-Munro
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

6.  Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors:  Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

7.  Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis.

Authors:  A M Taylor; A Bush; A Thomson; P J Oades; J L Marchant; C Bruce-Morgan; J Holly; L Ahmed; D B Dunger
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

8.  Long-term survival and nutritional data in patients with cystic fibrosis treated in a Danish centre.

Authors:  M Nir; S Lanng; H K Johansen; C Koch
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

Review 9.  Nutritional management of cystic fibrosis.

Authors:  A MacDonald
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

10.  Disproportionate ileal digestion on canine food consumption. A possible model for satiety in pancreatic insufficiency.

Authors:  J H Meyer; J D Elashoff; J E Doty; Y G Gu
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.